(Q55052893)

English

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Pe

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Pe (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

chronic inflammatory demyelinating polyradiculoneuropathy

0 references

0 references

Eduardo Nobile-Orazio

9

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

European Federation of Neurological Societies

14

object named as

European Federation of Neurological Societies

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

author name string

P Y K Van den Bergh

1

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

R D M Hadden

2

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

P Bouche

3

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

D R Cornblath

4

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

A Hahn

5

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

I Illa

6

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

C L Koski

7

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

J-M Léger

8

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

J Pollard

10

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

C Sommer

11

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

P A van Doorn

12

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

I N van Schaik

13

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

Peripheral Nerve Society

15

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

publication date

1 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

European Journal of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

17

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

3

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

356-363

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02930.X

21 January 2018

Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02930.X

21 January 2018

Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02930.X

21 January 2018

Relapsing demyelinating disease affecting both the central and peripheral nervous systems

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02930.X

21 January 2018

Peripheral neuropathy in patients with inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02930.X

21 January 2018

Utility of the distal compound muscle action potential duration for diagnosis of demyelinating neuropathies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02930.X

21 January 2018

Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02930.X

21 January 2018

Pulsed high dose dexamethasone treatment in chronic inflammatory demyelinating polyneuropathy: a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02930.X

21 January 2018

Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02930.X

21 January 2018

Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02930.X

21 January 2018

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02930.X

21 January 2018

Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02930.X

21 January 2018

EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02930.X

21 January 2018

A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02930.X

21 January 2018

Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: the ICE Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02930.X

21 January 2018

EFNS guidelines on neuropathic pain assessment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02930.X

21 January 2018

Identifiers

10.1111/J.1468-1331.2009.02930.X

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20456730

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55052893&oldid=1008918489"